Translation and validation of a Japanese version of the irritable bowel syndrome-quality of life measure (IBS-QOL-J)

BioPsychoSocial Medicine

Volumn 1, Issue , 2007, Pages

  Kanazawa, Motoyori ^a   Drossman, Douglas A ^c   Shinozaki, Masae ^a   Sagami, Yasuhiro ^b   Endo, Yuka ^b   Palsson, Olafur S ^c   Hongo, Michio ^b   Whitehead, William E ^c   Fukudo, Shin ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34250882062     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1186/1751-0759-1-6     Document Type: Article

References (31)

1. Drossman DA Li Z Andruzzi E Temple RD Talley NJ Thompson WG Whitehead WE Janssens J Funch-Jensen P Corazziari E Richter JE Koch GG U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact Dig Dis Sci 1993 38 1569-1580 10.1007/ BF01303162 8359066
2. Locke GR 3rd Weaver AL Melton LJ 3rd Talley NJ Psychosocial factors are linked to functional gastrointestinal disorders: A population based nested case-control study Am J Gastroenterol 2004 99 350-357 10.1111/ j.1572-0241.2004.04043.x 15046228
3. Gralnek IM Hays RD Kilbourne A Naliboff B Mayer EA The impact of irritable bowel syndrome on health-related quality of life Gastroenterology 2000 119 654-660 10.1053/gast.2000.16484 10982758
4. Frank L Kleinman L Rentz A Ciesla G Kim JJ Zacker C Health-related quality of life associated with irritable bowel syndrome: Comparison with other chronic diseases Clin Ther 2002 24 675-689 10.1016/ S0149-2918(02)85143-8 12017411
5. Drossman DA Sandler RS McKee DC Lovitz AJ Bowel patterns among subjects not seeking health care. Use of a questionnaire to identify a population with bowel dysfunction Gastroenterology 1982 83 529-534 7095360
6. Kanazawa M Endo Y Whitehead WE Kano M Hongo M Fukudo S Patients and nonconsulters with irritable bowel syndrome reporting a parental history of bowel problems have more impaired psychological distress Dig Dis Sci 2004 49 1046-1053 10.1023/B:DDAS.0000034570.52305.10 15309899
7. Whitehead WE Burnett CK Cook EW 3rd Taub E Impact of irritable bowel syndrome on quality of life Dig Dis Sci 1996 41 2248-2253 10.1007/ BF02071408 8943980
8. Ware JE Sherbourne CD The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection Med Care 1992 30 473-483 10.1097/00005650-199206000-00002 1593914
9. Drossman DA Creed FH Olden KW Svedlund J Toner BB Whitehead WE Psychosocial aspects of the functional gastrointestinal disorders Rome II The Functional Gastrointestinal Disorders McLean, VA: Degnon Associates Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE 2 2000 157-245
10. Guyatt GH Feeny DH Patrick DL Measuring health-related quality of life Ann Intern Med 1993 118 622-629 8452328
11. Drossman DA Inflammatory bowel disease Quality of life and pharmacoeconomics in clinical trials New York: Raven Press Spilker B 2 1966 925-935
12. Patrick DL Drossman DA Frederick IO DiCesare J Puder KL Quality of life in persons with irritable bowel syndrome: Development and validation of a new measure Dig Dis Sci 1998 43 400-411 10.1023/A:1018831127942 9512138
13. McKenna SP A new theoretical approach to the measurement of quality of life Drug Inf J 1994 28 13-18
14. Drossman DA Patrick DL Whitehead WE Toner BB Diamant NE Hu Y Jia H Bangdiwala SI Further validation of the IBS-QOL: A disease-specific quality-of-life questionnaire Am J Gastroenterol 2000 95 999-1007 10.1111/j.1572-0241.2000.01941.x 10763950
15. Drossman DA Whitehead WE Toner BB Diamant N Hu YJ Bangdiwala SI Jia H What determines severity among patients with painful functional bowel disorders? Am J Gastroenterol 2000 95 974-980 10.1111/ j.1572-0241.2000.01936.x 10763947
16. Akehurst RL Brazier JE Mathers N O'Keefe C Kaltenthaler E Morgan A Platts M Walters SJ Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting Pharmacoeconomics 2002 20 455-462 10.2165/00019053-200220070-00003 12093301
17. Wang W Pan G Qian J Cognitive therapy for patients with refractory irritable bowel syndrome [in Chinese with English abstract] Zhonghua Nei Ke Za Zhi 2002 41 156-159 11940313
18. Drossman DA Toner BB Whitehead WE Diamant NE Dalton CB Duncan S Emmot S Proffitt V Akman D Frusciante K Le T Meyer K Bradshaw B Mikula K Morris CB Blackman CJ Hu Y Jia H Li JZ Koch GG Bangdiwala SI Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders Gastroenterology 2003 125 19-31 10.1016/S0016-5085(03)00669-3 12851867
19. Whitehead WE Levy RL Von Korff M Whitehead WE Levy RL Von Korff M Feld AD Palsson OS Turner M Drossman DA The usual medical care for irritable bowel syndrome Aliment Pharmacol Ther 2004 20 1305-1315 10.1111/ j.1365-2036.2004.02256.x 15606392
20. Blanchard EB Lackner JM Gusmano R Gudleski GD Sanders K Keefer L Krasner S Prediction of treatment outcome among patients with irritable bowel syndrome treated with group cognitive therapy Behav Res Ther 2006 44 317-337 10.1016/j.brat.2005.01.003 16413495
21. Park JM Choi MG Oh JH Cho YK Lee IS Kim SW Choi KY Chung IS Cross-cultural validation of irritable bowel syndrome quality of life in Korea Dig Dis Sci 2006 51 1478-1484 10.1007/s10620-006-9084-6 16855882
22. Shinozaki M Kanazawa M Sagami Y Endo Y Hongo M Drossman DA Whitehead WE Fukudo S Validation of the Japanese version of the Rome II modular questionnaire and irritable bowel syndrome severity index J Gastroenterol 2006 41 491-494 10.1007/s00535-006-1799-9 16799892
23. Drossman DA Talley NJ Whitehead WE Thompson WG Corazziari E Research diagnostic questions for functional gastrointestinal disorders: Rome II Modular Questionnaire: Investigations and Respondent Forms Rome II The Functional Gastrointestinal Disorders McLean, VA: Degnon Associates Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE 2 2000 669-714
24. Longstreth GF Thompson WG Chey WD Houghton LA Mearin F Spiller RC Functional bowel disorders Gastroenterology 2006 130 1480-1491 10.1053/ j.gastro.2005.11.061 16678561
25. Francis CY Morris J Whorwell PJ The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progress Aliment Pharmacol Ther 1997 11 395-402 10.1046/ j.1365-2036.1997.142318000.x 9146781
26. Lembo A Ameen VZ Drossman DA Irritable bowel syndrome: Toward an understanding of severity Clin Gastroenterol Hepatol 2005 3 717-725 10.1016/S1542-3565(05)00157-6 16233998
27. Hahn BA Kirchdoerfer LJ Fullerton S Mayer E Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome Aliment Pharmacol Ther 1997 11 547-552 10.1046/j.1365-2036.1997.00168.x 9218081
28. Bijkerk CJ de Wit NJ Muris JW Jones RH Knottnerus JA Hoes AW Outcome measures in irritable bowel syndrome: Comparison of psychometric and methodological characteristics Am J Gastroenterol 2003 98 122-127 10.1111/j.1572-0241.2003.07158.x 12526947
29. Gill D Sharpe M Frequent consulters in general practice: A systematic review of studies of prevalence, associations and outcome J Psychosom Res 1999 47 115-130 10.1016/S0022-3999(98)00118-4 10579496
30. Hobara M Beliefs about appropriate pain behavior: Cross-cultural and sex differences between Japanese and Euro-Americans Eur J Pain 2005 9 389-393 10.1016/j.ejpain.2004.09.006 15979019
31. Ide M Fugl-Meyer AR Life satisfaction in persons with spinal cord injury: A comparative investigation between Sweden and Japan Spinal Cord 2001 39 387-393 10.1038/sj.sc.3101171 11464313